Pioneering 3D Human Tissues for Drug Discovery

Sep 08 | 2023

Organovo to Participate in the H.C. Wainwright Global Investment Conference

Read More »

Aug 23 | 2023

Organovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 Data

Read More »

Mar 21 | 2023

Organovo Announces FXR Program

Read More »